New ‘wonder’ drug helps in safer weight lose

Washington, Sept 27: A researcher at Tel Aviv University’s Sackler School of Medicine has developed what could be a new weight-loss wonder drug, which not only quells the desire to consume fatty foods, but also has fewer side effects.

Dr. Nir Barak developed the drug in conjunction with the drug company Obecure.

The drug, called HistaleanTM, is based on betahistine, an approved drug used for the treatment of vertigo.

Global warming affecting North America’s northernmost lake

NATO forces kill 170 Taliban in Afghanistan’s Helmand province

Kabul, Sep 27 : US-led coalition troops backed by warplanes have killed about 170 Taliban militants in two major battles in southern Afghanistan. A US-led coalition soldier has also died in the operation.

Fighting with the insurgents erupted on Tuesday in Helmand, a Taliban stronghold, and continued till Wednesday, a statement from the US-led coalition said.

"The initial estimate by a ground forces commander assessed that more than 104 insurgents were killed thus far in the engagement," it said. The figures could not be verified independently.

New drug holds hope for cancer patients

Washington, Sept 27 : American researchers have developed a new drug, that when administered along with chemotherapy, shows promise in treating advanced melanoma, delaying the progression of cancer and prolonging the lives of patients.

The new drug, STA-4783, is the first in a new class called oxidative stress inducers.

C-difficile, inflammatory bowel disease combo quadruples death risk

Washington, Sept 27 : A new research has revealed that patients with both Clostridium difficile infection (C-difficile) and inflammatory bowel disease (IBD) like Crohn’s disease or ulcerative colitis, are four times more likely to die than patients with just IBD or C difficile infection.

Clostridium difficile infection is the main cause of diarrhoea among patients, and in recent years, the numbers of new cases of the infection have been steadily increasing.

Borneo caves provide clues to climate change over last 25,000 years

Washington, Sept 27 : A study of caves of the tropical Pacific island of Borneo has helped scientists understand how the Earth’s climate suddenly changed several times over the last 25,000 years.

Georgia Tech Asst. Prof. Kim Cobb and graduate student Jud Partin analyzed stalagmites, pillar-like rock formations that stem from the ground in caves, to produce a high-resolution and continuous record of the climate over the equatorial rainforest.

Pages

News in Focus

Tata Consultancy Services (TCS) Share Price Target at Rs 3,900: Sharekhan Research

In its latest research update, Mirae Asset Sharekhan maintains a BUY recommendation on Tata Consultancy Services (TCS), India’s IT bellwether, despite a challenging quarter marked by subdued revenu

Glenmark Pharmaceuticals Share Price Target at Rs 2,430: Motilal Oswal Research

Motilal Oswal has reiterated its BUY rating on Glenmark Pharmaceuticals, setting a compelling price target of Rs 2,430—implying a robust 28% upside from current levels.

Exness Registrations Ban on Indian Users; Detailed Review and Implication of Forex Trading on Non-FIU Complaint Platforms

Exness has stopped new memberships in India and there isn't any clarification from the company regarding this change.

How Typography Enhances Readability and Visual Appeal in Posters

Typography is one of the most crucial elements of poster design.

SBI Life Share Price Jumps 1.37 Percent; Immediate Resistance at Rs 1,862

SBI Life Share price jumped 1.37 percent on Friday and the stock is currently looking bullish on technical charts. We could face minor resistance in range of Rs 1,860 - 1,875.

Crompton Greaves Consumer Share Price Target at Rs 410: Kotak Securities

Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.